45 results
8-K
EX-10.1
ADAP
Adaptimmune Therapeutics Plc
16 Dec 20
Departure of Directors or Certain Officers
5:01pm
to such person’s hiring by Executive.
In this Agreement, “Restricted Person” means anyone employed or engaged either (i) directly by the Company
8-K
EX-10.1
ADAP
Adaptimmune Therapeutics Plc
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
the six (6) months prior to such person’s hiring by Employee.
In this Agreement, “Restricted Person” means anyone employed or engaged either (i
10-K
2016 FY
EX-10.19
ADAP
Adaptimmune Therapeutics Plc
13 Mar 17
Annual report
12:00am
by the Company or any affiliated company at any time during the six (6) months prior to such person’s hiring by Executive.
In this Agreement, “Restricted
8-K
EX-10.1
ADAP
Adaptimmune Therapeutics Plc
1 Aug 19
New Executive Team Announced at Adaptimmune
7:22am
prior to such person’s hiring by Executive.
In this Agreement, “Restricted Person” means anyone employed or engaged by the Company or any affiliated
8-K
EX-10.01
ADAP
Adaptimmune Therapeutics Plc
26 Jan 22
Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer
8:05am
time during the six (6) months prior to such person’s hiring by Executive.
In this Agreement, “Restricted Person” means anyone employed or engaged
10-K
EX-10.20
i1b9 iqea
13 Mar 17
Annual report
12:00am
8-K
EX-10.1
mpotkmjau7tuv4 5t
27 Feb 24
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company’s Sarcoma Franchise
8:13am
8-K
EX-10.1
fbsq2
27 Jun 19
Departure of Directors or Certain Officers
8:08am
20-F
EX-4.9
3ekvk91x
13 Oct 15
Annual report (foreign)
12:00am
20-F
EX-4.11
h1vumq7b
13 Oct 15
Annual report (foreign)
12:00am
20-F
EX-4.10
iwff7wxnp
13 Oct 15
Annual report (foreign)
12:00am
20-F
EX-4.8
b51to8k4ne
13 Oct 15
Annual report (foreign)
12:00am
20-F
EX-4.15
8eoxt
13 Oct 15
Annual report (foreign)
12:00am